AmyElizabethRothbergMD

Diabetes, Obesity

Clinical Professor, Internal Medicine, University of Michigan Medical School; Professor, Nutritional Sciences, School of Public Health, University of Michigan

Join to view full profile

Dr. Rothberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rothberg's full profile

Already have an account?

Office
24 Frank Lloyd Wright Dr
Ann Arbor, MI 48105
Phone+1 734-647-5871

Summary

Dr. Amy Rothberg is an endocrinologist in Ann Arbor, MI and is affiliated with multiple hospitals in the area, including University of Michigan Medical Center, Michigan Medicine, Veterans Affairs Ann Arbor Healthcare System, St. Joseph Mercy Chelsea, and St Joseph's Healthcare. She received her medical degree from Wayne State University School of Medicine and has been in practice 21 years. She specializes in obesity, diabetes and metabolism.

Education & Training

University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
University of MichiganResidency, Internal Medicine, 1996 - 1999
Wayne State University School of MedicineClass of 1996

Certifications & Licensure

MI State Medical License 1999 - 2027
GA State Medical License 2023 - 2025
MN State Medical License 2021 - 2025
SC State Medical License 2022 - 2025
WI State Medical License 2021 - 2023
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

The Effects of an Intensive Lifestyle Intervention on Reproductive Outcomes Start of enrollment: 2013 Jul 01
Completed
Not Applicable
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance Start of enrollment: 2009 Aug 01
Recruiting
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight Start of enrollment: 2015 Nov 01
Completed
Not Applicable
The Effects of Gastric or Duodenal Nutrient Infusion on Food Intake, Obesity and Comorbidities in Obese Individuals Start of enrollment: 2016 Aug 01
Completed
Not Applicable
Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes Start of enrollment: 2018 Apr 10
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

138 citations
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
Matthew C. Riddle, William T. Cefalu, Philip Evans, Hertzel C. Gerstein, Michael A. Nauck
The Journal of Clinical Endocrinology and Metabolism. 2021-08-30
5 citations
The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study.
Jamy D Ard, Ian J Neeland, Amy E Rothberg, Robert J Chilton, Daniel de Luis
Diabetes, Obesity & Metabolism. 2024-03-01
28 citations
Prevalence and change of central obesity among US Asian adults: NHANES 2011–2014
Xuefeng Liu, Yang Chen, Nicole Boucher, Amy E. Rothberg
BMC Public Health. 2017-08-25

Press Mentions

Move over Ozempic — Even More Powerful Weight-Loss Drug Is in the Works – NationalApril 27th, 2023
Even Stronger Obesity Drug Could Further Upend Weight-Loss CareApril 27th, 2023
New Obesity Drug Tirzepatide Poised to Upend Weight Loss CareApril 27th, 2023
Join now to see all